Provided by Tiger Fintech (Singapore) Pte. Ltd.

Telomir Pharmaceuticals

4.12
-0.0500-1.20%
Post-market: 4.200.0800+1.94%18:23 EDT
Volume:150.84K
Turnover:617.46K
Market Cap:122.62M
PE:-7.36
High:4.57
Open:4.12
Low:3.91
Close:4.17
Loading ...

Telomir Pharmaceuticals Announces Breakthrough: Telomir-1 Reverses Calcium Dysregulation, the Hidden Driver of Aging and Disease, in Multiple Human Cell Lines

ACCESS Newswire
·
26 Feb

Telomir Pharmaceuticals Inc - Telomir-1 Reduces Intracellular Calcium Overload & Mitigates Oxidative Stress

THOMSON REUTERS
·
26 Feb

Telomir Pharmaceuticals Says Telomir-1 Compound Stabilizes Silver for Advanced Medical Applications

MT Newswires Live
·
21 Feb

Telomir says captured, stabilized silver in biologically compatible form

TIPRANKS
·
21 Feb

Telomir Pharmaceuticals Achieves Breakthrough in Silver Ion Stabilization, Unlocking a Multi-Billion-Dollar Medical Market

ACCESS Newswire
·
21 Feb

TELO Announces Breakthrough

Zacks Small Cap Research
·
21 Feb

Telomir Pharmaceuticals, Inc. (TELO) Receives a New Rating from Rodman & Renshaw

TIPRANKS
·
21 Feb

Telomir Pharmaceuticals Announces Significant Reduction of Oxidative Stress in Human Retinal Cell Lines, Advancing Potential Treatment for Age-Related Macular Degeneration (AMD)

ACCESS Newswire
·
18 Feb

Telomir Pharmaceuticals: Telomir-1 Treatment Resulted in a Significant Reduction of Ros Elevation

THOMSON REUTERS
·
18 Feb

TELO Again Announces Breakthrough Results

Zacks Small Cap Research
·
18 Feb

Telomir Pharmaceuticals files $150M mixed securities shelf

TIPRANKS
·
15 Feb

Telomir Pharmaceuticals Inc Files for Mixed Shelf of up to $150 Mln - SEC Filing

THOMSON REUTERS
·
15 Feb

TELO Improves Balance Sheet

Zacks Small Cap Research
·
05 Feb

Telomir Pharmaceuticals announces results from preclinical studies of Telomir-1

TIPRANKS
·
28 Jan

Telomir Pharmaceuticals Announces Breakthrough Results With Telomir-1 Fully Reversing Oxidative Stress in Human Cell Lines and Exploring Potential as a Treatment for Avian Influenza (Bird Flu) and Other Viruses

ACCESS Newswire
·
28 Jan

BRIEF-Telomir Pharmaceuticals Announces Breakthrough Results With Telomir-1

Reuters
·
28 Jan